Evidence-Based Medicine Guidelines
Histamine-2-receptor antagonists and antacids in critically ill patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Histamine-2-receptor Antagonists and Antacids in Critically Ill Patients." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453234/all/Histamine_2_receptor_antagonists_and_antacids_in_critically_ill_patients.
Histamine-2-receptor antagonists and antacids in critically ill patients. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/453234/all/Histamine_2_receptor_antagonists_and_antacids_in_critically_ill_patients. Accessed March 23, 2025.
Histamine-2-receptor antagonists and antacids in critically ill patients. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/453234/all/Histamine_2_receptor_antagonists_and_antacids_in_critically_ill_patients
Histamine-2-receptor Antagonists and Antacids in Critically Ill Patients [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 23]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453234/all/Histamine_2_receptor_antagonists_and_antacids_in_critically_ill_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Histamine-2-receptor antagonists and antacids in critically ill patients
ID - 453234
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453234/all/Histamine_2_receptor_antagonists_and_antacids_in_critically_ill_patients
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
